393 related articles for article (PubMed ID: 26419316)
1. Ethanol Enhances TGF-β Activity by Recruiting TGF-β Receptors From Intracellular Vesicles/Lipid Rafts/Caveolae to Non-Lipid Raft Microdomains.
Huang SS; Chen CL; Huang FW; Johnson FE; Huang JS
J Cell Biochem; 2016 Apr; 117(4):860-71. PubMed ID: 26419316
[TBL] [Abstract][Full Text] [Related]
2. DMSO Enhances TGF-β Activity by Recruiting the Type II TGF-β Receptor From Intracellular Vesicles to the Plasma Membrane.
Huang SS; Chen CL; Huang FW; Hou WH; Huang JS
J Cell Biochem; 2016 Jul; 117(7):1568-79. PubMed ID: 26587792
[TBL] [Abstract][Full Text] [Related]
3. 7-Dehydrocholesterol (7-DHC), But Not Cholesterol, Causes Suppression of Canonical TGF-β Signaling and Is Likely Involved in the Development of Atherosclerotic Cardiovascular Disease (ASCVD).
Huang SS; Liu IH; Chen CL; Chang JM; Johnson FE; Huang JS
J Cell Biochem; 2017 Jun; 118(6):1387-1400. PubMed ID: 27862220
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells.
Chen CL; Chen CY; Chen YP; Huang YB; Lin MW; Wu DC; Huang HT; Liu MY; Chang HW; Kao YC; Yang PH
J Biomed Sci; 2016 Feb; 23():30. PubMed ID: 26922801
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib suppresses TGF-β responses by inducing caveolae/lipid raft-mediated internalization/degradation of cell-surface type II TGF-β receptors: Implications in development of effective adjunctive therapy for hepatocellular carcinoma.
Chung CL; Wang SW; Sun WC; Shu CW; Kao YC; Shiao MS; Chen CL
Biochem Pharmacol; 2018 Aug; 154():39-53. PubMed ID: 29678520
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors.
Chen CL; Huang SS; Huang JS
J Cell Physiol; 2008 Apr; 215(1):223-33. PubMed ID: 17972267
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis.
Chen CL; Liu IH; Fliesler SJ; Han X; Huang SS; Huang JS
J Cell Sci; 2007 Oct; 120(Pt 20):3509-21. PubMed ID: 17878231
[TBL] [Abstract][Full Text] [Related]
8. Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells.
Chen CL; Wu DC; Liu MY; Lin MW; Huang HT; Huang YB; Chen LC; Chen YY; Chen JJ; Yang PH; Kao YC; Chen PY
J Recept Signal Transduct Res; 2017 Apr; 37(2):189-199. PubMed ID: 27401208
[TBL] [Abstract][Full Text] [Related]
9. Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells.
Chen CL; Huang SS; Huang JS
J Biol Chem; 2006 Apr; 281(17):11506-14. PubMed ID: 16492675
[TBL] [Abstract][Full Text] [Related]
10. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components.
Head BP; Patel HH; Roth DM; Murray F; Swaney JS; Niesman IR; Farquhar MG; Insel PA
J Biol Chem; 2006 Sep; 281(36):26391-9. PubMed ID: 16818493
[TBL] [Abstract][Full Text] [Related]
11. Caveolae facilitate but are not essential for platelet-activating factor-mediated calcium mobilization and extracellular signal-regulated kinase activation.
Poisson C; Rollin S; Véronneau S; Bousquet SM; Larrivée JF; Le Gouill C; Boulay G; Stankova J; Rola-Pleszczynski M
J Immunol; 2009 Aug; 183(4):2747-57. PubMed ID: 19620302
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
[TBL] [Abstract][Full Text] [Related]
13. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.
Zhao B; Wang Q; Du J; Luo S; Xia J; Chen YG
Cell Res; 2012 Oct; 22(10):1467-78. PubMed ID: 22710801
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-2 is a negative regulator of anti-proliferative function and signaling of transforming growth factor-β in endothelial cells.
Xie L; Vo-Ransdell C; Abel B; Willoughby C; Jang S; Sowa G
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C1161-74. PubMed ID: 21832243
[TBL] [Abstract][Full Text] [Related]
15. Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae.
Awasthi V; Mandal SK; Papanna V; Rao LV; Pendurthi UR
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1447-55. PubMed ID: 17413039
[TBL] [Abstract][Full Text] [Related]
16. Methods for the study of signaling molecules in membrane lipid rafts and caveolae.
Ostrom RS; Insel PA
Methods Mol Biol; 2006; 332():181-91. PubMed ID: 16878693
[TBL] [Abstract][Full Text] [Related]
17. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover.
Di Guglielmo GM; Le Roy C; Goodfellow AF; Wrana JL
Nat Cell Biol; 2003 May; 5(5):410-21. PubMed ID: 12717440
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.
Zhang XL; Topley N; Ito T; Phillips A
J Biol Chem; 2005 Apr; 280(13):12239-45. PubMed ID: 15661740
[TBL] [Abstract][Full Text] [Related]
19. Endocytic regulation of TGF-beta signaling.
Chen YG
Cell Res; 2009 Jan; 19(1):58-70. PubMed ID: 19050695
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.
Chen W; Jump DB; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):18-26. PubMed ID: 17197511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
